Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.45 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.43 |
| ▸ | S100A4 | P26447 | 2/20 | 0.37 |
| ▸ | PTPRC | P08575 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 3/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.36 |
| ▸ | GAA | P10253 | 3/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.36 |
| ▸ | NPC1 | O15118 | 3/20 | 0.36 |
| ▸ | RAB9A | P51151 | 3/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | APAF1 | O14727 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | RECQL | P46063 | 1/20 | 0.36 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11667714 | 0.87 | S100A4 (0.44) | ALDH1A1TDP1HSD17B10S100A4PTPRC | |
| SCHEMBL11659636 | 0.81 | TDP1 (0.41) | ALDH1A1TDP1S100A4PTPRCLMNA | |
| SCHEMBL11661848 | 0.81 | TSHR (0.33) | ALDH1A1TDP1HSD17B10MAPTKMT2A | |
| SCHEMBL11660608 | 0.81 | MAPT (0.39) | ALDH1A1TDP1HSD17B10MAPTL3MBTL1 | |
| SCHEMBL11664823 | 0.75 | PTPRC (0.44) | ALDH1A1TDP1HSD17B10S100A4PTPRC | |
| SCHEMBL16131477 | 0.73 | PTPN1 (0.40) | ALDH1A1TDP1PTPN1HSD17B10S100A4 | |
| SCHEMBL8075442 | 0.73 | — | — | |
| SCHEMBL1287837 | 0.70 | ALDH1A1 (0.74) | ALDH1A1TDP1PTPN1HSD17B10S100A4 | |
| SCHEMBL30535903 | 0.70 | ALDH1A1 (0.74) | ALDH1A1TDP1PTPN1HSD17B10S100A4 | |
| SCHEMBL11665729 | 0.69 | CYP19A1 (0.42) | ALDH1A1TDP1LMNAL3MBTL1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130172273-A1 | CYCLOTETRAPEPTIDES WITH PRO-ANGIOGENIC PROPERTIES | GENETADI BIOTECH, S.L. (ES) | 2013-07-04 | — | — | US | disclosed |
| EP-2593471-A1 | CYCLOTETRAPEPTIDES WITH PRO-ANGIOGENIC PROPERTIES | GENETADI Biotech, S.L. (ES) | 2013-05-22 | — | — | EP | disclosed |
| WO-2012007562-A1 | CYCLOTETRAPEPTIDES WITH PRO-ANGIOGENIC PROPERTIES | GENETADI BIOTECH, S.L. (ES) | 2012-01-19 | — | — | WO | disclosed |
| EP-2407478-A1 | New cyclotetrapeptides with pro-angiogenic properties | GENETADI Biotech, S.L. (ES) | 2012-01-18 | — | — | EP | disclosed |
| US-4068298-A | Information storage and retrieval system | SYSTEMS DEVELOPMENT CORPORATION (US) | 1978-01-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130172273-A1 | CYCLOTETRAPEPTIDES WITH PRO-ANGIOGENIC PROPERTIES | FLT1, TIE1, VIP | ALDH1A1 1840/4885TDP1 3930/4885PTPN1 4266/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.